Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Ascendis Pharma A (ASND) over the last 14 years, with Q4 2025 value amounting to $225.4 million.

  • Ascendis Pharma A's Non-Current Assets rose 7776.98% to $225.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $225.4 million, marking a year-over-year increase of 7776.98%. This contributed to the annual value of $218.8 million for FY2025, which is 7257.07% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Non-Current Assets of $225.4 million as of Q4 2025, which was up 7776.98% from $160.1 million recorded in Q3 2025.
  • In the past 5 years, Ascendis Pharma A's Non-Current Assets registered a high of $1.3 billion during Q4 2021, and its lowest value of $126.8 million during Q4 2024.
  • In the last 5 years, Ascendis Pharma A's Non-Current Assets had a median value of $164.0 million in 2023 and averaged $247.9 million.
  • As far as peak fluctuations go, Ascendis Pharma A's Non-Current Assets surged by 634055.96% in 2021, and later plummeted by 8672.05% in 2022.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Non-Current Assets stood at $1.3 billion in 2021, then tumbled by 86.72% to $169.6 million in 2022, then dropped by 22.07% to $132.2 million in 2023, then decreased by 4.1% to $126.8 million in 2024, then surged by 77.77% to $225.4 million in 2025.
  • Its Non-Current Assets was $225.4 million in Q4 2025, compared to $160.1 million in Q3 2025 and $152.8 million in Q2 2025.